Moreover, the anti-cancer effect of epigallocatechin gallate (EGCG) molecules has been shown by its action on the inhibition of ribosomal protein SA (RPSA)/67LR, suggesting that the receptor could be an interesting target for reducing tumor growth [21, 22]. The gene discussed is RPSA; the disease is cancer.